These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 9749883)
1. Maternal sickle cell anemia and neonatal isoimmunization. Narchi H; Ekuma-Nkama E Int J Gynaecol Obstet; 1998 Aug; 62(2):129-34. PubMed ID: 9749883 [TBL] [Abstract][Full Text] [Related]
2. The influence of infant and maternal sickle cell disease on birth outcome and neonatal course. Brown AK; Sleeper LA; Pegelow CH; Miller ST; Gill FM; Waclawiw MA Arch Pediatr Adolesc Med; 1994 Nov; 148(11):1156-62. PubMed ID: 7921116 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for alloimmunization by patients with sickle cell disease. Murao M; Viana MB Braz J Med Biol Res; 2005 May; 38(5):675-82. PubMed ID: 15917948 [TBL] [Abstract][Full Text] [Related]
4. The unreliability of amniotic fluid bilirubin measurements in isoimmunized pregnancies in sickle cell disease patients. Hadi HA; Fadel HE; Nelson GH; Hill J Obstet Gynecol; 1985 May; 65(5):758-60. PubMed ID: 3920595 [TBL] [Abstract][Full Text] [Related]
5. Hemolytic disease of the fetus and newborn due to minor blood group alloimmunization in a mother of sickle cell disease with multiple alloantibodies. Varghese S; Prakash S; Mukherjee S; Sahu A; Mishra D Asian J Transfus Sci; 2023; 17(2):291-294. PubMed ID: 38274971 [TBL] [Abstract][Full Text] [Related]
6. Red blood cell alloimmunization in sickle cell disease patients in Uganda. Natukunda B; Schonewille H; Ndugwa C; Brand A Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Aygun B; Padmanabhan S; Paley C; Chandrasekaran V Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310 [TBL] [Abstract][Full Text] [Related]
8. The Rh blood group system and its role in alloimmunization rate among sickle cell disease and sickle thalassemia patients in Iran. Jalali Far MA; Oodi A; Amirizadeh N; Mohammadipour M; Keikhaei Dehdezi B Mol Genet Genomic Med; 2021 Mar; 9(3):e1614. PubMed ID: 33547762 [TBL] [Abstract][Full Text] [Related]
9. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study. Koshy M; Burd L; Wallace D; Moawad A; Baron J N Engl J Med; 1988 Dec; 319(22):1447-52. PubMed ID: 3054555 [TBL] [Abstract][Full Text] [Related]
10. Late hyporegenerative anemia in neonates with rhesus hemolytic disease. al-Alaiyan S; al Omran A J Perinat Med; 1999; 27(2):112-5. PubMed ID: 10379500 [TBL] [Abstract][Full Text] [Related]
11. Alloimmunization in sickle cell anemia in the era of extended red cell typing. O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932 [TBL] [Abstract][Full Text] [Related]
12. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review. Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266 [TBL] [Abstract][Full Text] [Related]
13. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. Vichinsky EP; Earles A; Johnson RA; Hoag MS; Williams A; Lubin B N Engl J Med; 1990 Jun; 322(23):1617-21. PubMed ID: 2342522 [TBL] [Abstract][Full Text] [Related]
14. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions. Wahl SK; Garcia A; Hagar W; Gildengorin G; Quirolo K; Vichinsky E Transfusion; 2012 Dec; 52(12):2671-6. PubMed ID: 22519830 [TBL] [Abstract][Full Text] [Related]
15. Pregnancy and sickle cell hemoglobinopathies: results with and without prophylactic transfusions. Cunningham FG; Pritchard JA; Mason R Obstet Gynecol; 1983 Oct; 62(4):419-24. PubMed ID: 6888818 [TBL] [Abstract][Full Text] [Related]
16. Neonatal outcome after fetal anemia managed by intrauterine transfusion. Garabedian C; Rakza T; Thomas D; Wibaut B; Vaast P; Subtil D; Houfflin-Debarge V Eur J Pediatr; 2015 Nov; 174(11):1535-9. PubMed ID: 26032762 [TBL] [Abstract][Full Text] [Related]
17. Morbidity of ABO haemolytic disease in the newborn. Bhat YR; Kumar CG Paediatr Int Child Health; 2012 May; 32(2):93-6. PubMed ID: 22595217 [TBL] [Abstract][Full Text] [Related]
18. [Foetal-maternal alloimmunizations in the South-East area of the Venice province]. Gessoni G; Valverde S; Giacomini A; Antico F; Salvadego M; Arreghini N; De Fusco G; Fezzi M; Marchiori G; Manoni F Minerva Ginecol; 2002 Aug; 54(4):333-8. PubMed ID: 12114866 [TBL] [Abstract][Full Text] [Related]
19. Morbidity and pregnancy outcomes associated with sickle cell anemia among Saudi women. Al Kahtani MA; AlQahtani M; Alshebaily MM; Abd Elzaher M; Moawad A; Aljohani N Int J Gynaecol Obstet; 2012 Dec; 119(3):224-6. PubMed ID: 22986097 [TBL] [Abstract][Full Text] [Related]
20. Advantages of larger volume, less frequent intrauterine red blood cell transfusions for maternal red cell alloimmunization. Inglis SR; Lysikiewicz A; Sonnenblick AL; Streltzoff JL; Bussel JB; Chervenak FA Am J Perinatol; 1996 Jan; 13(1):27-33. PubMed ID: 8645382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]